spec sheet9 rows
Dyphylline is a xanthine-derivative bronchodilator that relaxes airway smooth muscle through nonselective phosphodiesterase inhibition and weak adenosine-receptor antagonism. Chemically 7-(2,3-dihydroxypropyl)-1,3-dimethylxanthine, it is a distinct synthetic methylxanthine rather than a theophylline salt, and unlike theophylline it is not metabolized to theophylline in the body but is instead cleared largely unchanged by the kidneys. Marketed for decades under names such as Dilor and Lufyllin (often combined with the expectorant guaifenesin), it is an FDA-approved agent used for the symptomatic relief of bronchospasm in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. Compared with theophylline it is a somewhat weaker bronchodilator on a milligram basis but carries a wider tolerability margin, a shorter half-life, and far fewer drug and smoking interactions because it bypasses hepatic CYP1A2 metabolism. More recent laboratory work has explored repurposing dyphylline as a coronavirus main-protease inhibitor and as a cAMP-raising activator of dormant ovarian follicles.
- Relieves bronchospasm in asthma, chronic bronchitis, and COPD
- Cleared unchanged by the kidneys, so it bypasses liver CYP1A2 metabolism
- Far fewer drug and smoking interactions than theophylline
- No conversion to theophylline in the body, giving predictable behavior
- Wider tolerability margin than aminophylline at comparable airway opening
- Gentlest methylxanthine in comparative toxicity screening
- Nausea, vomiting, and stomach upset
- Headache, restlessness, and insomnia
- Tremor, palpitations, and fast heartbeat
- Risk of accumulation and toxicity in kidney impairment
Overview
Dyphylline is the quietly sensible member of the xanthine family; it does pretty much everything theophylline does for the airways, but without the white-knuckle blood-level monitoring. The big selling point is that it skips the liver almost entirely; roughly 80-plus percent leaves unchanged in the urine, so it essentially doesn't care whether you smoke, what CYP1A2 inhibitors you're on, or how your liver enzymes are running that week; that alone makes it a cleaner ride than classic theophylline.
It's a bit milder as a bronchodilator gram-for-gram, and the half-life is short so it needs steady dosing, but in head-to-head work it matched aminophylline for opening airways while throwing fewer side effects. In the zebrafish methylxanthine screen it was hands down the gentlest of the bunch, lowest toxicity across the board. The newer coronavirus-protease and ovarian-follicle papers are early lab work and are better read as interesting rather than proven, but they show the molecule still has legs. Honest note; it's still a stimulant xanthine, so nausea, jitters, and fast heartbeat are on the table, and the renal-clearance angle cuts both ways if your kidneys are impaired.
Mechanism
Dyphylline is a methylxanthine that relaxes bronchial and vascular smooth muscle primarily by inhibiting phosphodiesterase (PDE), the enzyme family that breaks down the intracellular second messengers cyclic AMP () and cyclic GMP (cGMP). By slowing that breakdown it raises cAMP levels, which reduces intracellular calcium availability and drives smooth-muscle relaxation, producing bronchodilation. It also acts as a competitive at A1 and A2A receptors (adenosine normally promotes bronchoconstriction and mast-cell mediator release), though this action is weaker than that of theophylline and contributes only modestly to its effect.
Secondary consequences of raised include mild cardiac and central-nervous-system stimulation and some diuresis. Pharmacokinetically dyphylline is distinct from theophylline; the 2,3-dihydroxypropyl substituent at the N7 position makes it more water soluble and, critically, resistant to hepatic CYP1A2 demethylation, so it is not converted to theophylline in vivo and is eliminated mostly unchanged by renal excretion, giving a short of roughly two hours and freedom from the CYP-mediated drug and smoking interactions that complicate theophylline dosing.
receptor fingerprint
Phosphodiesterase (PDE)Nonselective inhibition
Bronchial smooth muscleRelaxation (downstream of raised cAMP)
A1 receptorCompetitive antagonist
A2A receptorCompetitive antagonist
Coronavirus main protease (Mpro/3CLpro)Inhibition (in vitro binding to catalytic dyad)
Dosingtypical ranges, not medical advice
interested in protocols and clinical dosages? make an account to see them! ^_^
Safetyrisks and cautions, not medical advice
Dyphylline shares the methylxanthine side-effect profile; nausea, vomiting, headache, restlessness, insomnia, tremor, palpitations, and tachycardia can occur, and very high serum levels have produced severe headache in volunteers. Because it is cleared almost entirely by the kidneys rather than the liver, dose accumulation and toxicity are a concern in renal impairment, while hepatic disease and smoking status matter far less than they do for theophylline.
It should be used cautiously in people with cardiac arrhythmias, active peptic ulcer, hyperthyroidism, or seizure disorders. It is a stimulant and can be additive with other xanthines and sympathomimetics. Older combination products paired it with guaifenesin, and rare cases of drug-induced liver injury have been catalogued in pharmacovigilance databases for xanthine products, so it is not risk-free; but on comparative tolerability it has generally shown fewer side effects than aminophylline at equivalent bronchodilation.
Subjective profileweighing the evidence above
A well-tolerated, renally-cleared xanthine bronchodilator that trades a little potency for a much wider safety margin and near-freedom from the drug and smoking interactions that plague theophylline; a solid, if old-school, respiratory agent with intriguing early repurposing research.
Resources
This entry is here for reference.
Research
- 1979first citedUrinary excretion of dyphylline in humans
- 1980controlled trial[Comparison of the bronchodilatatory efficacy of oral methylxanthines (author's transl)].
- 2024most recentTheophylline derivatives promote primordial follicle activation via cAMP-PI3K/Akt pathway and a…
- 1.Urinary excretion of dyphylline in humans
- 2.[Comparison of the bronchodilatatory efficacy of oral methylxanthines (author's transl)].
- 3.Methylxanthines induce structural and functional alterations of the cardiac system in zebrafish embryos
- 4.Caffeine and caffeine-containing pharmaceuticals as promising inhibitors for 3-chymotrypsin-like protease of SARS-CoV-2
- 5.Repurposing dyphylline as a pan-coronavirus antiviral therapy
- 6.Theophylline derivatives promote primordial follicle activation via cAMP-PI3K/Akt pathway and ameliorate fertility deficits in naturally aged mice
6 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
What is dyphylline used for?
It is an FDA-approved xanthine bronchodilator used to relieve and prevent bronchospasm in asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). It was sold under names like Dilor and Lufyllin, often combined with the expectorant guaifenesin.
How does dyphylline work?
It relaxes airway smooth muscle mainly by inhibiting phosphodiesterase, which raises the intracellular messenger cAMP, and by weakly blocking adenosine receptors. Both actions promote bronchodilation and open the airways.
How is dyphylline different from theophylline?
Unlike theophylline, dyphylline is not metabolized by the liver into theophylline; it is excreted mostly unchanged by the kidneys. That means it has a short half-life, is not affected by smoking or CYP1A2-interacting drugs, but does need caution in kidney impairment.
Is dyphylline well-researched?
Yes for its respiratory use; human pharmacokinetic and comparative bronchodilator trials date back to the 1970s and 1980s. Newer laboratory work exploring it as a coronavirus protease inhibitor and an ovarian-follicle activator is early-stage and not yet clinically proven.
What are the main side effects of dyphylline?
As a stimulant xanthine it can cause nausea, headache, restlessness, insomnia, tremor, and fast heartbeat. Because it leaves through the kidneys, people with reduced kidney function are more prone to accumulation and toxicity.
Adverse effects
- Nausea, vomiting, and stomach upset
- Headache, restlessness, and insomnia
- Tremor, palpitations, and fast heartbeat
- Risk of accumulation and toxicity in kidney impairment
Notes and cautions
- Short half-life requires steady, repeated dosing